Wendell David Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-415
Closed -$204K 159
2017
Q2
$204K Buy
+415
New +$204K 0.04% 143
2016
Q1
Sell
-455
Closed -$247K 148
2015
Q4
$247K Hold
455
0.05% 141
2015
Q3
$212K Hold
455
0.04% 146
2015
Q2
$232K Buy
455
+10
+2% +$5.1K 0.05% 145
2015
Q1
$201K Buy
+445
New +$201K 0.04% 148